Loading

JSM Arthritis

Surgical Treatment of the Avascular Necrosis of the Hip Development Disorder

Original Research | Open Access | Volume 2 | Issue 1

  • 1. Clinic for Vascular Surgery, University Clinical Center Sarajevo, Bosnia and Herzegovina
  • 2. Clinic for Orthopedics and Traumatology, University Clinical Center Sarajevo, Bosnia and Herzegovina
+ Show More - Show Less
Corresponding Authors
Ismet Gavrankapetanovi?, Clinic for Orthopedics and Traumatology, University Clinical Center Sarajevo, Bolni?ka 25, 71000 Sarajevo, Bosnia and Herzegovina, Tel: 387-33-297-600
Abstract

The purpose of this research is to evaluate the consequences of an operative treatment of hip developmental disorder in children and to analyze the research results and make a recommendation for the following treatment dilemma: when is the optimal time for an operative treatment of a hip development disorder?

The research is a retrospective and observational analysis based on the classification of indirect radiological signs of local vascular disorder by the Buacholz-Ogden’s scale. Materials used for this research are medical records of treated patients at the Clinic for Orthopedics and Traumatology of the Sarajevo University Clinical Center. Using a random selection, two groups of 30 patients with hip development disorder have been formed. The first group is comprised of patients aged between 6 to 18 months and the second group of patients aged between 18 and 60 months. The medical records used for this research included all necessary anamnestic details and postoperative state treatments with clinical findings and regular radiological check-up findings that include the presence or absence of the ossification nucleus as well as its position.

The results of this study show that the performance of a surgical treatment during the age between 12 and 20 months is burdened by the highest percentage of avascular necrosis. Even though AVN can be noticed in other age groups, according to the results of our research, it seems that vascular supply of the hip is the most vulnerable in the period between 12 and 20 months.

Keywords

• Avascular necrosis
• Hip development disorder
• Treatment
• Surgery

CITATION

Hadžimehmedagi? A, Gavrankapetanovi? I, Papovi? A, Jamakosmanovi? M, Baždar E (2017) Surgical Treatment of the Avascular Necrosis of the Hip Development Disorder. JSM Arthritis 2(1): 1019.

ABBREVIATIONS

AVN: Avascular Necrosis

INTRODUCTION

Branching of the blood vessels of the proximal femur is different than any other joint. This scheme changes during the individual’s development, dynamically depending on age. Namely, the caliber, blood flow rate and dominance of certain arteries from the entire network of vessels that participate in hip blood supply are not equally expressed in all stages of development. In each successive stage, blood supply is dominated by a different artery that, after a certain period of time, shifts its major role to another artery [1]. Anastomoses between individual arteries are not constant in all stages of development and they represent a great importance for compensatory mechanisms.

The disturbance of local arterial blood vessels, at a time when they dominate the blood supply and affect the quality of hip development and maturation, leads to reduced perfusion, and consequently, to the lack of development, ossification and possible osteonecrosis [2].

Knowing the nature of luxation and the hip development disorder, as well as knowing the importance of vascularization of the proximal femoral part for vitality of the specific region and its successful development through childhood and adolescence, is a task in which the main problem remains to preserve vitality and functionality of cartilaginous and bone tissue [3,4]. In addition, there are clear indications defined by orthopedic standards on which patients to select for surgical treatment of developmental hip dysplasia. At the same time, there is increasing debate on which age group surgery should be performed on and whether it should be done in one or two acts [5]. Hips that were supposed to be treated in early childhood, as well as hips treated with ignorance of this problem, often because of vulnerable vascular supply, after completion of growth are subject to the degenerative changes that are being compensated in youth, but in the further evolution represent a disabling factor.

MATERIALS AND METHODS

This research is a retrospective and observational analysis based on the classification of indirect radiological signs of a local vascular disorder based on the Bucholz-Ogden’s scale.

Materials used for this research are medical records of patients treated at the Clinic for Orthopedics and Traumatology of the Sarajevo University Clinical Center. Using a random selection, two groups of 30 patients with hip development disorder have been made. The first group is comprised of patients aged between 6 and 18 months and the second group of patients aged between 18 and 60 months. The study sample is made up of children with a basic disorder – a hip luxation without any comorbidity that could affect eventual changes in bone structure of the femoral head. Medical records used for this research included all necessary anamnestic details and postoperative state treatments with clinical findings and regular radiological check-up findings that include the presence or absence of the ossification nucleus and its position. All patients underwent surgeries with the same operative technique that was performed by the same surgeon. Operative treatment included bloody reposition and anterior approach to the hip (Smith-Petersen approach). For all patients in the age group between 18 and 60 months operative technique included bloody reposition, osteotomy of the proximal femoral part with abbreviation, varus correction and derotation and for all of these patients Salter’s pelvis osteotomy was performed.

RESULTS AND DISCUSSION

In total, there were 60 patients who underwent surgery for developmental dysplasia of one or both hips between the ages of 6 and 60 months. Out of 60 patients, only 10 (16.6%) were male while 50 (83.3%) were female (a ratio of 5:1). Research showed that dislocation is predominantly a disease affecting female children, 4-10 times more often than male children [6,7]. Patients were divided into two groups - the first group classified children that underwent surgery between the ages of 6 and 18 months, while the other group included children that underwent surgery between the ages 1.5 and 5 years.

Family history refers to the occurrence of a similar or the same disease only among the closest relatives (a sister, brother, father or mother). From the total sample, there was a history in 15% of the cases; or by groups it was positive in 16.6% of cases in group 1 and 13.3 % of cases in the group 2.

The type of birth and the intrauterine position were correlated with congenital luxation or the existence of a less valuable hip. According to research by Clausen and Nielsen, the breech position carries the risk of dislocation and dysplasia with a rate of 13.3% [8]. This study addressed the time of delivery, but with incidence of 86.6% in the first and 93.3% in the second group on-time delivery dates, there was no statistical significance for further relation of date of birth and eventual development of avascular necrosis.

The previous treatment refers to the period between setting up the diagnosis and starting the surgical treatment. Senaran had a hypothesis in his study that the optimal treatment of developmental hip dysplasia can be achieved using Pavlick’s belts during the first two months of life, and then, if conservative treatment fails to produce a good result, bloody reposition should be performed no later than 3 months of age.

All studies that have researched events on hips have registered the importance of the presence of an ossification nucleus which indirectly indicates the existence of high-quality vascular supply or guaranteed conditions for progress in the development and maturation of the entire hip [9-11]. In the group of patients aged between 18 and 60 months, in which an ossification nucleus has been present at all stages of the follow-up (100%), the group that includes patients of up to 18 months of age, showed presence of the same in 62.2%. To evaluate the success of a surgical treatment of developmental hip dysplasia by Salter, there should be at least one year of postoperative follow-up for indirect signs of the vascular supply disorder of proximal femur to register signs of avascular necrosis (AVN). All patients in this study had a long enough follow-up period up to 72 months on average. Given that follow-up period, the first group of patients enjoyed longer and thus higher-quality follow-up period. From the total sample, there were 24 (32 %) cases with no signs of AVN or only mild and reversible signs of AVN (type 0 and type 1). However, 51 of them (68 %) had manifested signs of AVN at the end of the follow-up period.

By observing the distribution of AVN in relation to age and time of the surgical procedure, in the first group, the concentration of the worst form of AVN (type IV) for patients who underwent surgery in a period between 12 and 18 months of age is evident. Patients in the second group, we do not form a significant concentration due to a wider range of variables.

CONCLUSION

Avascular necrosis of varying degrees can also be a complication of the treatment of developmental dysplasia of the hip, which in many cases is characterized by the subsequent development of premature osteoarthritis.

Avascular necrosis is a common complication of surgical procedures that aim to permanently regulate the position of related elements of the hip. Current literature records the frequency of these complications ranging from 0% to 73%, compared to the variability of diagnosis. This variability has not changed since 1990 when the incidence ranged from 3-60%, which directly depends on the authors, their protocols and the length of the follow-up period [12]. In this study, postoperative complications of AVN, were mostly found in children operated for developmental hip dysplasia in the age group between 6 and 18 months and as contrasted to the group aged between 18 and 60 months. In group 1, the presence of AVN expressed a significance of 1.1813 E - 09, while in the second group it was expressed with a significance of 7.0745 E – 10, a finding which answers our initial research dilemma: the optimal time for an operative treatment would be in the second group of patients because of their lower incidence of AVN, which is directly connected to the anatomic distribution of the hip vascular scheme. The degree of morphological changes in further development of proximal femur and the subsequent disability are proportional to the degree of vascular damage. The results of this study show that the performance of a surgical treatment during the age between 12 and 20 months is burdened by the highest percentage of a vascular necrosis. Even though AVN can be noticed in other age groups, according to the results of our research, it seems that vascular supply of the hip is the most vulnerable in the period between 12 and 20 months.

REFERENCES

1. Kalhor M, Horowitz K, Gharehdaghi J, Beck M, Ganz R. Anatomic variations in femoral head circulation. Hip Int. 2012; 22: 307-312.

2. Zlotorowicz M, Szczodry M, Czubak J, Ciszek B. Anatomy of the medial femoral circumflex artery with respect to the vascularity of the femoral head. J Bone Joint Surg Br. 2011; 93: 1471-1474.

3. Hernigou P, Habibi A, Bachir D, Galacteros F. The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease. J Bone Joint Surg Am. 2006; 88: 2565-2572.

4. Drescher W, Li H, Lundgaard A, Bunger C, Hansen E.S. Endothelin-1- Induced Femoral Head Epiphyseal Artery Constriction Is Enhanced by Long-Term Corticosteroid Treatment. J Bone Joint Surg Am. 2006; 88: 173-179.

5. Remmel E, Schraml A, Stauner K, Schuh A. Long-term results after two-stage operative treatment of late developmental displacement of the hip. Int Orthop. 2009; 33: 1095-1100.

6. Lynn T. Staheli. Developmental hip dysplasia in Fundamentals of the pediatric orthopedics. Williams & Wilkins. 2007; 208-219.

7. Williams H, Johnson KJ. Developmental Dysplasia of the Hip. In imaging of the hip and bony pelvis. Birkhauser. 2005; 107-141.

8. Clausen I, Nielsen KT. Breech position, delivery route and congenital hip dislocation. Acta Obstet Gynecol Scand. 1988; 67: 595-597.

9. Aaron RK, Dyke JP, Ciombor DM, Ballon D, Lee J, Jung E, et al. Perfusion abnormalities in subchondral bone associated with marrow edema, osteoarthritis, and avascular necrosis. Ann N Y Acad Sci. 2007; 1117: 124-137.

10. Connolly P, Weinstein SL. The course and treatment of avascular necrosis of the femoral head in developmental dysplasia of the hip. Acta Orthop Traumatol Turc. 2007; 41: 54-59.

11. Lafforgue P. Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine. 2006; 73: 500-507.

12. Compion J, Benson M. Developmental dysplasia of the hip: Surgery. 2007; 25: 176-180.

Hadžimehmedagi? A, Gavrankapetanovi? I, Papovi? A, Jamakosmanovi? M, Baždar E (2017) Surgical Treatment of the Avascular Necrosis of the Hip Development Disorder. JSM Arthritis 2(1): 1019.

Received : 11 Nov 2016
Accepted : 03 Jan 2017
Published : 05 Jan 2017
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X